Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter McIntyre

Showing results (151-160 of 235) with videos related to

Pageof 24
Sort By:
BJOG : an International Journal of Obstetrics and Gynaecology|October 18, 2024
Birth Outcomes After Pertussis and Influenza Diagnosed in Pregnancy: A Retrospective, Population-Based StudyJane E Frawley, Wen-Qiang He, Lisa McCallum, et al.
Vaccine|April 19, 2011
Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years oldPatrick Quinn, Michael Gold, Jenny Royle, et al.
British Journal of Pharmacology|January 10, 2015
GPCR-mediated EGF receptor transactivation regulates TRPV4 action in the vasculatureMahmoud Saifeddine, Mahmoud El-Daly, Koichiro Mihara, et al.
Communicable Diseases Intelligence (2018)|August 25, 2020
Australian mumps serosurvey 2012-2013: any cause for concern?Cyra Patel, Frank Beard, Alexandra Hendry, et al.
Frontiers in Pharmacology|February 8, 2019
The TRPV4 Agonist GSK1016790A Regulates the Membrane Expression of TRPV4 ChannelsSara Baratchi, Peter Keov, William G Darby, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 9, 2012
7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivityMark S Nash, Peter McIntyre, Alex Groarke, et al.
Biomicrofluidics|November 8, 2014
Examination of the role of transient receptor potential vanilloid type 4 in endothelial responses to shear forcesSara Baratchi, Francisco J Tovar-Lopez, Khashayar Khoshmanesh, et al.
Vaccine|February 1, 2022
Pertussis burden and acellular pertussis vaccine effectiveness in high risk childrenSarah Sheridan, Peter McIntyre, Bette Liu, et al.
The Pediatric Infectious Disease Journal|September 27, 2014
Predictors of disease severity in children hospitalized for pertussis during an epidemicHelen Marshall, Michelle Clarke, Kavita Rasiah, et al.
Neuropharmacology|September 24, 2002
Cloning and functional characterization of the guinea pig vanilloid receptor 1Jonathan Savidge, Clare Davis, Kirti Shah, et al.
Pageof 24

Showing results (151-160 of 235) with videos related to

Sort By:
Pageof 24
BJOG : an International Journal of Obstetrics and Gynaecology|October 18, 2024
Birth Outcomes After Pertussis and Influenza Diagnosed in Pregnancy: A Retrospective, Population-Based StudyJane E Frawley, Wen-Qiang He, Lisa McCallum, et al.
Vaccine|April 19, 2011
Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years oldPatrick Quinn, Michael Gold, Jenny Royle, et al.
British Journal of Pharmacology|January 10, 2015
GPCR-mediated EGF receptor transactivation regulates TRPV4 action in the vasculatureMahmoud Saifeddine, Mahmoud El-Daly, Koichiro Mihara, et al.
Communicable Diseases Intelligence (2018)|August 25, 2020
Australian mumps serosurvey 2012-2013: any cause for concern?Cyra Patel, Frank Beard, Alexandra Hendry, et al.
Frontiers in Pharmacology|February 8, 2019
The TRPV4 Agonist GSK1016790A Regulates the Membrane Expression of TRPV4 ChannelsSara Baratchi, Peter Keov, William G Darby, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 9, 2012
7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivityMark S Nash, Peter McIntyre, Alex Groarke, et al.
Biomicrofluidics|November 8, 2014
Examination of the role of transient receptor potential vanilloid type 4 in endothelial responses to shear forcesSara Baratchi, Francisco J Tovar-Lopez, Khashayar Khoshmanesh, et al.
Vaccine|February 1, 2022
Pertussis burden and acellular pertussis vaccine effectiveness in high risk childrenSarah Sheridan, Peter McIntyre, Bette Liu, et al.
The Pediatric Infectious Disease Journal|September 27, 2014
Predictors of disease severity in children hospitalized for pertussis during an epidemicHelen Marshall, Michelle Clarke, Kavita Rasiah, et al.
Neuropharmacology|September 24, 2002
Cloning and functional characterization of the guinea pig vanilloid receptor 1Jonathan Savidge, Clare Davis, Kirti Shah, et al.
Pageof 24